Medicine at Cambridge
@medcambridge.bsky.social
Updates on the latest research, news, and events from the Department of Medicine, University of Cambridge.
Part of @cambridge-scm.bsky.social @cam.ac.uk
Based on @cambridgebiocampus.bsky.social
https://www.med.cam.ac.uk/
Part of @cambridge-scm.bsky.social @cam.ac.uk
Based on @cambridgebiocampus.bsky.social
https://www.med.cam.ac.uk/
Pinned
Last Friday, our Department came together at our Annual Research Day 2025 to share discoveries, spark new ideas, and build the collaborations that will carry us forward.
Discover the highlights ➡️ buff.ly/wDaHWGC
@medcambridge.bsky.social #ResearchDay
@vpd-hlri.bsky.social
Discover the highlights ➡️ buff.ly/wDaHWGC
@medcambridge.bsky.social #ResearchDay
@vpd-hlri.bsky.social
Upcoming seminar:
🎓Prof Andreas Pichlmair, @dzif.bsky.social
📢"Virus‐host interactomics identify pathogen restriction factors and highlight the importance of non-canonical regulatory processes for antiviral immunity"
📅 4:30-5:30PM, Thur 20 November
📍JCBC @cambridgebiocampus.bsky.social
#CITIID
🎓Prof Andreas Pichlmair, @dzif.bsky.social
📢"Virus‐host interactomics identify pathogen restriction factors and highlight the importance of non-canonical regulatory processes for antiviral immunity"
📅 4:30-5:30PM, Thur 20 November
📍JCBC @cambridgebiocampus.bsky.social
#CITIID
November 14, 2025 at 4:45 PM
Upcoming seminar:
🎓Prof Andreas Pichlmair, @dzif.bsky.social
📢"Virus‐host interactomics identify pathogen restriction factors and highlight the importance of non-canonical regulatory processes for antiviral immunity"
📅 4:30-5:30PM, Thur 20 November
📍JCBC @cambridgebiocampus.bsky.social
#CITIID
🎓Prof Andreas Pichlmair, @dzif.bsky.social
📢"Virus‐host interactomics identify pathogen restriction factors and highlight the importance of non-canonical regulatory processes for antiviral immunity"
📅 4:30-5:30PM, Thur 20 November
📍JCBC @cambridgebiocampus.bsky.social
#CITIID
A needle-free nasal spray designed to prevent life-threatening allergic reactions is now available in the UK.
Our Affiliated Associate Professor Shuaib Nasser at @cuh.nhs.uk spoke to @dailymail.co.uk on the treatment’s potential: buff.ly/LXnDpbj
Our Affiliated Associate Professor Shuaib Nasser at @cuh.nhs.uk spoke to @dailymail.co.uk on the treatment’s potential: buff.ly/LXnDpbj
Nasal spray developed to treat allergic reactions now available in UK
Called Neffy, it offers a needle-free alternative to the EpiPen used by those at risk of potentially fatal anaphylaxis to inject themselves with adrenaline.
buff.ly
November 13, 2025 at 10:30 AM
A needle-free nasal spray designed to prevent life-threatening allergic reactions is now available in the UK.
Our Affiliated Associate Professor Shuaib Nasser at @cuh.nhs.uk spoke to @dailymail.co.uk on the treatment’s potential: buff.ly/LXnDpbj
Our Affiliated Associate Professor Shuaib Nasser at @cuh.nhs.uk spoke to @dailymail.co.uk on the treatment’s potential: buff.ly/LXnDpbj
🦠 Meet the Pandemic Preparedness theme leads for our new MPhil in Translational Medical Research — Dr Nicholas Matheson & Dr Suzannah Rihn @lab-rihn-th.bsky.social.
Hear their welcome and see how science today readies us for future health challenges.
Apply today: buff.ly/nQzXX4U
Hear their welcome and see how science today readies us for future health challenges.
Apply today: buff.ly/nQzXX4U
November 11, 2025 at 12:02 PM
🦠 Meet the Pandemic Preparedness theme leads for our new MPhil in Translational Medical Research — Dr Nicholas Matheson & Dr Suzannah Rihn @lab-rihn-th.bsky.social.
Hear their welcome and see how science today readies us for future health challenges.
Apply today: buff.ly/nQzXX4U
Hear their welcome and see how science today readies us for future health challenges.
Apply today: buff.ly/nQzXX4U
Reposted by Medicine at Cambridge
Children and young people faced higher and longer-lasting risks of rare heart complications after #COVID19 infection than after vaccination, say @vpd-hlri.bsky.social researchers.
Find out more about this study 👇
bit.ly/43BmUof 🧪
Find out more about this study 👇
bit.ly/43BmUof 🧪
Risk of rare heart complications in children higher after COVID-19 infection than after vaccination
Children and young people faced long-lasting and higher risks of rare heart and inflammatory complications after COVID-19 infection, compared to before or
bit.ly
November 6, 2025 at 9:46 AM
Children and young people faced higher and longer-lasting risks of rare heart complications after #COVID19 infection than after vaccination, say @vpd-hlri.bsky.social researchers.
Find out more about this study 👇
bit.ly/43BmUof 🧪
Find out more about this study 👇
bit.ly/43BmUof 🧪
Ahead of the Grand Finale of this year’s Postdoc Venture Creation Challenge, we spoke with Dr Elena Pavlova — scientist-turned-founder of Protalea Bio, a standout finalist aiming to prevent age-related diseases like cancer before they start.
Read more👉 buff.ly/sxOgnc9
@cam.ac.uk
Read more👉 buff.ly/sxOgnc9
@cam.ac.uk
Stopping cancer before it starts: the Cambridge venture redefining age-related disease prevention | Department of Medicine
Ahead of the Grand Finale of this year’s Postdoc Venture Creation Challenge, we spoke with Dr Elena Pavlova, the scientist-turned-founder behind Protalea Bio, one of this year’s standout finalists…
buff.ly
November 5, 2025 at 3:35 PM
Ahead of the Grand Finale of this year’s Postdoc Venture Creation Challenge, we spoke with Dr Elena Pavlova — scientist-turned-founder of Protalea Bio, a standout finalist aiming to prevent age-related diseases like cancer before they start.
Read more👉 buff.ly/sxOgnc9
@cam.ac.uk
Read more👉 buff.ly/sxOgnc9
@cam.ac.uk
⏳ Less than a month to secure funding for our new MPhil in Translational Medical Research!
Curious how it could launch your research career? Join our course director Harriet Groom this Friday at 1:00–1:45 PM for an exclusive webinar.
Register here: buff.ly/KhQw4jb
@cam.ac.uk
Curious how it could launch your research career? Join our course director Harriet Groom this Friday at 1:00–1:45 PM for an exclusive webinar.
Register here: buff.ly/KhQw4jb
@cam.ac.uk
November 4, 2025 at 11:01 AM
⏳ Less than a month to secure funding for our new MPhil in Translational Medical Research!
Curious how it could launch your research career? Join our course director Harriet Groom this Friday at 1:00–1:45 PM for an exclusive webinar.
Register here: buff.ly/KhQw4jb
@cam.ac.uk
Curious how it could launch your research career? Join our course director Harriet Groom this Friday at 1:00–1:45 PM for an exclusive webinar.
Register here: buff.ly/KhQw4jb
@cam.ac.uk
Upcoming seminar:
🎓Prof Mark Cragg, Professor in Experimental Cancer Biology @unisouthampton.bsky.social
📢"Engineering antibodies for agonism: from Fc to Fab"
📅 4:30-5:30PM, Thur 13 November
📍JCBC @cambridgebiocampus.bsky.social
buff.ly/ijFXZRF
#CITIID
🎓Prof Mark Cragg, Professor in Experimental Cancer Biology @unisouthampton.bsky.social
📢"Engineering antibodies for agonism: from Fc to Fab"
📅 4:30-5:30PM, Thur 13 November
📍JCBC @cambridgebiocampus.bsky.social
buff.ly/ijFXZRF
#CITIID
November 3, 2025 at 2:29 PM
Upcoming seminar:
🎓Prof Mark Cragg, Professor in Experimental Cancer Biology @unisouthampton.bsky.social
📢"Engineering antibodies for agonism: from Fc to Fab"
📅 4:30-5:30PM, Thur 13 November
📍JCBC @cambridgebiocampus.bsky.social
buff.ly/ijFXZRF
#CITIID
🎓Prof Mark Cragg, Professor in Experimental Cancer Biology @unisouthampton.bsky.social
📢"Engineering antibodies for agonism: from Fc to Fab"
📅 4:30-5:30PM, Thur 13 November
📍JCBC @cambridgebiocampus.bsky.social
buff.ly/ijFXZRF
#CITIID
Upcoming seminar:
🎓Dr Anneliese Speak, @medcambridge.bsky.social
📢"Zombies, ninjas and all things killer cells"
📅 4:30-5:30PM, Thur 30 October
📍JCBC @cambridgebiocampus.bsky.social
buff.ly/KIFGG1F
#CITIID
🎓Dr Anneliese Speak, @medcambridge.bsky.social
📢"Zombies, ninjas and all things killer cells"
📅 4:30-5:30PM, Thur 30 October
📍JCBC @cambridgebiocampus.bsky.social
buff.ly/KIFGG1F
#CITIID
October 24, 2025 at 9:30 AM
Upcoming seminar:
🎓Dr Anneliese Speak, @medcambridge.bsky.social
📢"Zombies, ninjas and all things killer cells"
📅 4:30-5:30PM, Thur 30 October
📍JCBC @cambridgebiocampus.bsky.social
buff.ly/KIFGG1F
#CITIID
🎓Dr Anneliese Speak, @medcambridge.bsky.social
📢"Zombies, ninjas and all things killer cells"
📅 4:30-5:30PM, Thur 30 October
📍JCBC @cambridgebiocampus.bsky.social
buff.ly/KIFGG1F
#CITIID
Congratulations to Professor Sarah Teichmann on being elected as a Regular Member of @nam.edu! A well-earned recognition of her outstanding leadership and impact in human biology, development & disease.👏
Read more: buff.ly/6SORb8O
@scicambridge.bsky.social @cam.ac.uk
Read more: buff.ly/6SORb8O
@scicambridge.bsky.social @cam.ac.uk
Professor Sarah Teichmann elected to US National Academy of Medicine | Department of Medicine
Professor Sarah Teichmann has been elected as a Regular Member of the National Academy of Medicine for her demonstrated excellence in systems biology, computational biology, and immunology.
www.med.cam.ac.uk
October 21, 2025 at 2:29 PM
Congratulations to Professor Sarah Teichmann on being elected as a Regular Member of @nam.edu! A well-earned recognition of her outstanding leadership and impact in human biology, development & disease.👏
Read more: buff.ly/6SORb8O
@scicambridge.bsky.social @cam.ac.uk
Read more: buff.ly/6SORb8O
@scicambridge.bsky.social @cam.ac.uk
Exciting milestone for the Hong Kong Jockey Club Global Health Institute 👏
Co-led by our Professor Ravi Gupta, the new joint lab at HKUMed will advance vaccine research and strengthen our shared commitment to global health innovation.
Read more: www.hkjcghi.org/hkjcghi-plaq...
Co-led by our Professor Ravi Gupta, the new joint lab at HKUMed will advance vaccine research and strengthen our shared commitment to global health innovation.
Read more: www.hkjcghi.org/hkjcghi-plaq...
October 20, 2025 at 11:21 AM
Exciting milestone for the Hong Kong Jockey Club Global Health Institute 👏
Co-led by our Professor Ravi Gupta, the new joint lab at HKUMed will advance vaccine research and strengthen our shared commitment to global health innovation.
Read more: www.hkjcghi.org/hkjcghi-plaq...
Co-led by our Professor Ravi Gupta, the new joint lab at HKUMed will advance vaccine research and strengthen our shared commitment to global health innovation.
Read more: www.hkjcghi.org/hkjcghi-plaq...
🚨 Job alert!
Research assistant (fixed term) to join @jamesnathanlab.bsky.social's group at #CITIID and work on the respiratory Mechanisms of Disease theme under the @cam.ac.uk-GSK Translational Immunology Collaboration (CG-TIC).
Apply by 2 November: buff.ly/XebIJaX
Research assistant (fixed term) to join @jamesnathanlab.bsky.social's group at #CITIID and work on the respiratory Mechanisms of Disease theme under the @cam.ac.uk-GSK Translational Immunology Collaboration (CG-TIC).
Apply by 2 November: buff.ly/XebIJaX
October 17, 2025 at 1:03 PM
🚨 Job alert!
Research assistant (fixed term) to join @jamesnathanlab.bsky.social's group at #CITIID and work on the respiratory Mechanisms of Disease theme under the @cam.ac.uk-GSK Translational Immunology Collaboration (CG-TIC).
Apply by 2 November: buff.ly/XebIJaX
Research assistant (fixed term) to join @jamesnathanlab.bsky.social's group at #CITIID and work on the respiratory Mechanisms of Disease theme under the @cam.ac.uk-GSK Translational Immunology Collaboration (CG-TIC).
Apply by 2 November: buff.ly/XebIJaX
T-Therapeutics, a Cambridge Enterprise Venture built on our Professor Allan Bradley's research, is reshaping cancer care.
Their OpTiMus® platform creates a near-unlimited database of optimal T cell receptors, enabling new immune-based targeted treatments.
buff.ly/UZsSs3l
@cam.ac.uk
Their OpTiMus® platform creates a near-unlimited database of optimal T cell receptors, enabling new immune-based targeted treatments.
buff.ly/UZsSs3l
@cam.ac.uk
T-Therapeutics: reshaping the clinical landscape for cancer patients
T-Therapeutics' OpTiMus® platform uses T cell receptors for personalised cancer therapies and targets autoimmune disorders.
buff.ly
October 17, 2025 at 9:02 AM
T-Therapeutics, a Cambridge Enterprise Venture built on our Professor Allan Bradley's research, is reshaping cancer care.
Their OpTiMus® platform creates a near-unlimited database of optimal T cell receptors, enabling new immune-based targeted treatments.
buff.ly/UZsSs3l
@cam.ac.uk
Their OpTiMus® platform creates a near-unlimited database of optimal T cell receptors, enabling new immune-based targeted treatments.
buff.ly/UZsSs3l
@cam.ac.uk
Reposted by Medicine at Cambridge
October 16, 2025 at 4:36 PM
Exciting to see two new expert lymph node research centres to be established in @cam.ac.uk as part of this national collaboration, with Professor Sarah Teichmann from @medcambridge.bsky.social & @scicambridge.bsky.social.
More details below 👇
More details below 👇
NEWS | Investment from the Medical Research Council (MRC) forefronts three UK universities in vital lymph node research
🔗 Read the article in full in the news section of the OVG website, link to the website located below ⬇️
🔗 Read the article in full in the news section of the OVG website, link to the website located below ⬇️
October 16, 2025 at 9:29 AM
Exciting to see two new expert lymph node research centres to be established in @cam.ac.uk as part of this national collaboration, with Professor Sarah Teichmann from @medcambridge.bsky.social & @scicambridge.bsky.social.
More details below 👇
More details below 👇
We're seeking 2️⃣ research associates to join Professor
@andresfloto.bsky.social's lab @vpd-hlri.bsky.social. You'll be part of a multidisciplinary team exploring antibiotic uptake, efflux & metabolism across multiple bacterial pathogens.
Apply before 27 October: buff.ly/SqfTX3A
@andresfloto.bsky.social's lab @vpd-hlri.bsky.social. You'll be part of a multidisciplinary team exploring antibiotic uptake, efflux & metabolism across multiple bacterial pathogens.
Apply before 27 October: buff.ly/SqfTX3A
October 15, 2025 at 2:22 PM
We're seeking 2️⃣ research associates to join Professor
@andresfloto.bsky.social's lab @vpd-hlri.bsky.social. You'll be part of a multidisciplinary team exploring antibiotic uptake, efflux & metabolism across multiple bacterial pathogens.
Apply before 27 October: buff.ly/SqfTX3A
@andresfloto.bsky.social's lab @vpd-hlri.bsky.social. You'll be part of a multidisciplinary team exploring antibiotic uptake, efflux & metabolism across multiple bacterial pathogens.
Apply before 27 October: buff.ly/SqfTX3A
Reposted by Medicine at Cambridge
📣 The November edition of the VPD-HLRI Monthly Seminar Series is here:
🗓 17 November 2025, 4pm
📍 VPD-HLRI, Room 88/89
🗓 17 November 2025, 4pm
📍 VPD-HLRI, Room 88/89
October 14, 2025 at 8:28 AM
📣 The November edition of the VPD-HLRI Monthly Seminar Series is here:
🗓 17 November 2025, 4pm
📍 VPD-HLRI, Room 88/89
🗓 17 November 2025, 4pm
📍 VPD-HLRI, Room 88/89
Upcoming seminar:
🎓Dr Fränze Progatzky @franzeprogatzky.bsky.social, @kiroxford.bsky.social @ox.ac.uk @ndorms.bsky.social
📢"Outside the brain: how glial cells orchestrate tissue immunity"
📅 4:30-5:30PM, Thur 16 October
📍JCBC @cambridgebiocampus.bsky.social
buff.ly/IPj6StT
#CITIID
🎓Dr Fränze Progatzky @franzeprogatzky.bsky.social, @kiroxford.bsky.social @ox.ac.uk @ndorms.bsky.social
📢"Outside the brain: how glial cells orchestrate tissue immunity"
📅 4:30-5:30PM, Thur 16 October
📍JCBC @cambridgebiocampus.bsky.social
buff.ly/IPj6StT
#CITIID
October 14, 2025 at 10:07 AM
Upcoming seminar:
🎓Dr Fränze Progatzky @franzeprogatzky.bsky.social, @kiroxford.bsky.social @ox.ac.uk @ndorms.bsky.social
📢"Outside the brain: how glial cells orchestrate tissue immunity"
📅 4:30-5:30PM, Thur 16 October
📍JCBC @cambridgebiocampus.bsky.social
buff.ly/IPj6StT
#CITIID
🎓Dr Fränze Progatzky @franzeprogatzky.bsky.social, @kiroxford.bsky.social @ox.ac.uk @ndorms.bsky.social
📢"Outside the brain: how glial cells orchestrate tissue immunity"
📅 4:30-5:30PM, Thur 16 October
📍JCBC @cambridgebiocampus.bsky.social
buff.ly/IPj6StT
#CITIID
We're #hiring!
Course Coordinator to help deliver and managed our new MPhil in Translational Medical Research, which aims to train future leaders who translate research outputs into real-world clinical advances.
📅 Apply by 30 October: buff.ly/e88j5Zp
@cam.ac.uk
Course Coordinator to help deliver and managed our new MPhil in Translational Medical Research, which aims to train future leaders who translate research outputs into real-world clinical advances.
📅 Apply by 30 October: buff.ly/e88j5Zp
@cam.ac.uk
October 10, 2025 at 9:25 AM
We're #hiring!
Course Coordinator to help deliver and managed our new MPhil in Translational Medical Research, which aims to train future leaders who translate research outputs into real-world clinical advances.
📅 Apply by 30 October: buff.ly/e88j5Zp
@cam.ac.uk
Course Coordinator to help deliver and managed our new MPhil in Translational Medical Research, which aims to train future leaders who translate research outputs into real-world clinical advances.
📅 Apply by 30 October: buff.ly/e88j5Zp
@cam.ac.uk
🎉 Congratulations to our CaRM section lead, Professor Martin Bennett from @vpd-hlri.bsky.social, on receiving @ukri.org funding for their innovative work at the intersection of #AI and cardiovascular medicine.
Read more: www.enterprise.cam.ac.uk/news/univers...
@cam.ac.uk
Read more: www.enterprise.cam.ac.uk/news/univers...
@cam.ac.uk
University of Cambridge projects awarded funding as part of UKRI’s new proof of concept programme
Four Cambridge research projects receive UKRI funding to develop inclusive, sustainable and health-focused innovations.
www.enterprise.cam.ac.uk
October 9, 2025 at 12:23 PM
🎉 Congratulations to our CaRM section lead, Professor Martin Bennett from @vpd-hlri.bsky.social, on receiving @ukri.org funding for their innovative work at the intersection of #AI and cardiovascular medicine.
Read more: www.enterprise.cam.ac.uk/news/univers...
@cam.ac.uk
Read more: www.enterprise.cam.ac.uk/news/univers...
@cam.ac.uk
Reposted by Medicine at Cambridge
It is with great sadness that the University shares the news of the death of Professor Sir John Gurdon, founder of the @gurdoninstitute.bsky.social
Read our tribute to the visionary Nobel Laureate and watch an interview from 2012, just after he won: https://bit.ly/4mM8o3r
Read our tribute to the visionary Nobel Laureate and watch an interview from 2012, just after he won: https://bit.ly/4mM8o3r
October 7, 2025 at 5:49 PM
It is with great sadness that the University shares the news of the death of Professor Sir John Gurdon, founder of the @gurdoninstitute.bsky.social
Read our tribute to the visionary Nobel Laureate and watch an interview from 2012, just after he won: https://bit.ly/4mM8o3r
Read our tribute to the visionary Nobel Laureate and watch an interview from 2012, just after he won: https://bit.ly/4mM8o3r
October 6, 2025 at 1:18 PM
Upcoming seminar:
🎓Dr Stacey Kigar @staceykigar.bsky.social @medcambridge.bsky.social
📢"Chronic stress-mediated effects on the immune system: links to mental health"
📅 1-2PM, Thur 2 October
📍JCBC @cambridgebiocampus.bsky.social
buff.ly/ggnAwDO
#CITIID #MedSky #ImmunoSky 🧪
🎓Dr Stacey Kigar @staceykigar.bsky.social @medcambridge.bsky.social
📢"Chronic stress-mediated effects on the immune system: links to mental health"
📅 1-2PM, Thur 2 October
📍JCBC @cambridgebiocampus.bsky.social
buff.ly/ggnAwDO
#CITIID #MedSky #ImmunoSky 🧪
September 29, 2025 at 12:30 PM
Upcoming seminar:
🎓Dr Stacey Kigar @staceykigar.bsky.social @medcambridge.bsky.social
📢"Chronic stress-mediated effects on the immune system: links to mental health"
📅 1-2PM, Thur 2 October
📍JCBC @cambridgebiocampus.bsky.social
buff.ly/ggnAwDO
#CITIID #MedSky #ImmunoSky 🧪
🎓Dr Stacey Kigar @staceykigar.bsky.social @medcambridge.bsky.social
📢"Chronic stress-mediated effects on the immune system: links to mental health"
📅 1-2PM, Thur 2 October
📍JCBC @cambridgebiocampus.bsky.social
buff.ly/ggnAwDO
#CITIID #MedSky #ImmunoSky 🧪
Reposted by Medicine at Cambridge
Join us today for the VPD-HLRI Monthly Seminar 🫀
📅 Mon 29 Sept, 4pm
📍 Room 88/89, VPD-HLRI, Cambridge
Speakers:
🔹 Steven Niederer – Building a digital heart
🔹 Tian Zhao – Immune modulation in atherosclerosis
Free & open to all!
#Cambridge #HeartResearch #HLRI
📅 Mon 29 Sept, 4pm
📍 Room 88/89, VPD-HLRI, Cambridge
Speakers:
🔹 Steven Niederer – Building a digital heart
🔹 Tian Zhao – Immune modulation in atherosclerosis
Free & open to all!
#Cambridge #HeartResearch #HLRI
September 29, 2025 at 10:00 AM
Join us today for the VPD-HLRI Monthly Seminar 🫀
📅 Mon 29 Sept, 4pm
📍 Room 88/89, VPD-HLRI, Cambridge
Speakers:
🔹 Steven Niederer – Building a digital heart
🔹 Tian Zhao – Immune modulation in atherosclerosis
Free & open to all!
#Cambridge #HeartResearch #HLRI
📅 Mon 29 Sept, 4pm
📍 Room 88/89, VPD-HLRI, Cambridge
Speakers:
🔹 Steven Niederer – Building a digital heart
🔹 Tian Zhao – Immune modulation in atherosclerosis
Free & open to all!
#Cambridge #HeartResearch #HLRI
Reposted by Medicine at Cambridge
Fantastic to play our part in this year’s Cambridge Alumni Festival - welcoming visitors for talks and tours of the VPD-HLRI.
@charlottesummers.bsky.social
@lukeflower.bsky.social
@charlottesummers.bsky.social
@lukeflower.bsky.social
September 26, 2025 at 2:08 PM
Fantastic to play our part in this year’s Cambridge Alumni Festival - welcoming visitors for talks and tours of the VPD-HLRI.
@charlottesummers.bsky.social
@lukeflower.bsky.social
@charlottesummers.bsky.social
@lukeflower.bsky.social
Reposted by Medicine at Cambridge
Read ‘Pre and Post antibiotic epoch: the historical spread of antimicrobial resistance’ from @sangerinstitute.bsky.social, @biology.ox.ac.uk @ox.ac.uk, @ukhsa.bsky.social @ebi.embl.org and others in @science.org, here ⤵️
www.science.org/doi/10.1126/...
www.science.org/doi/10.1126/...
Pre- and postantibiotic epoch: The historical spread of antimicrobial resistance
Plasmids are now the primary vectors of antimicrobial resistance, but our understanding of how human industrialisation of antibiotics influenced their evolution is limited by a paucity of data predati...
www.science.org
September 26, 2025 at 9:14 AM
Read ‘Pre and Post antibiotic epoch: the historical spread of antimicrobial resistance’ from @sangerinstitute.bsky.social, @biology.ox.ac.uk @ox.ac.uk, @ukhsa.bsky.social @ebi.embl.org and others in @science.org, here ⤵️
www.science.org/doi/10.1126/...
www.science.org/doi/10.1126/...